Cohort study on imaging methods for cerebrovascular disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a multi-center and multi-modality imaging standard cohort for patients with cerebrovascular disease. It will analyze various imaging techniques to understand the mechanisms affecting prognosis and explore potential therapeutic targets. Approximately 800 patients aged 18-80 years with ischemic or hemorrhagic stroke will be recruited within 7 days of symptom onset. The study will collect baseline information and imaging data, with primary and secondary outcomes focusing on functional outcomes and complications over a year.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 18 and 80 years old;
* Onset of symptoms within 7 days;
* Clinical diagnosis of cerebrovascular disease (ischemic stroke or hemorrhagic stroke) confirmed by head imaging (CT or MRI);
* Signed informed consent form.

Exclusion Criteria:

* Diagnosed with non-cerebrovascular diseases (such as central nervous system infections, epilepsy, and metabolic encephalopathy);
* Patients with contraindications to multimodal CT or MRI, functional near-infrared imaging, or those who cannot cooperate to complete the relevant examinations;
* Patients with a life expectancy of less than 3 months or those who cannot complete the study follow-up due to other reasons.

Where it's running

• Beijing Tiantan Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: zixiao Li, PhD
• Email: lizixiao2008@hotmail.com
• Phone: 00861067013383

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brain recovery after MCA reopening is studied with PET/MR

  This study tests how brain blood flow, metabolism, and networks change after reopening a non-acute atherosclerotic middle cerebral artery occlusion in adults receiving recanalization treatment.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07927569

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy

  This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.

  Recruiting at 24 sites Phase 3 Hanyang University · Busan, Busan and 23 other locations · NCT07687706

• Scalp nerve block with liposomal versus standard bupivacaine for post-craniotomy pain relief

  This trial will test whether adding liposomal bupivacaine to scalp nerve blocks gives longer, better pain relief than standard bupivacaine for adults after elective craniotomy.

  Recruiting Phase 4 Zhejiang University · Hangzhou, Zhejiang · NCT07049094

• Using QDSA technology to assess cerebrovascular diseases

  This study is trying to see if a new imaging technology can help doctors better understand and treat patients with cerebrovascular diseases by tracking their health over time.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT06902415

• Portable EEG to triage suspected stroke patients in ambulances

  This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT06871969

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.